Zhejiang Boner Medical Investment Management Co., Ltd. announced that it has raised more than CNY 800 million in a round of funding led by new investor, Xiamen C&D Emerging Industry Equity Investment Co., Ltd. on November 9, 2023. The transaction also included participation from new investors, Sunshine Life Insurance Corporation Limited, Lake Bleu Capital (Hong Kong) Limited, China Pacific Insurance (Group) Co., Ltd., GY Capital, October Capital and other institutions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.78 CNY | +0.42% | -0.45% | +21.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.03% | 34.4B | |
+6.87% | 102B | |
+9.49% | 101B | |
-11.17% | 85.47B | |
+21.65% | 75.42B | |
+20.29% | 30.21B | |
+13.27% | 28.89B | |
-3.22% | 16.59B | |
-14.98% | 14.22B | |
+19.69% | 12.68B |
- Stock Market
- Equities
- 601601 Stock
- News China Pacific Insurance (Group) Co., Ltd.
- Zhejiang Boner Medical Investment Management Co., Ltd. announced that it has received CNY 800 million in funding from Xiamen C&D Emerging Industry Equity Investment Co., Ltd., Sunshine Life Insurance Corporation Limited, Lake Bleu Capital (Hong Kong) Limited, China Pacific Insurance Co., Ltd., GY Capital, October Capital and other investors